Human proteomics: from the operating room to the lab and back

Years of research and innovation within the cell and gene therapy space are rapidly showing signs of success, as an ever-increasing list of therapeutics have either already been approved for clinical use or are set to burst on the scene. Biomanufacturers have developed cutting-edge processes to create these life-saving compounds. Still, safety is always a paramount concern, and companies are constantly looking for new ways to improve their product and pipelines. Subvisible particle contamination is the leading cause of drug product recalls and a critical quality attribute, and improved modalities to easily detect and identify these particles are crucial.

More than US$55 billion has been invested in developing gene modification and cell therapy platforms over the past three years. While the science has advanced, the practical components of launch and optimizing

This webinar will provide an introduction to biotechnology products for regulatory affairs professionals.

The scientific experience is critical to the success and efficiency of the entire laboratory ecosystem – from software and instruments to workflows and processes. Scientists need to be able to focus on their critical work and not be burdened by challenges such as siloed data, manual processes and old technology.